New WHO meta-study: Mobile phones do not increase the risk of cancer – Human – Science and technology

After analyzing 63 studies from 1994 to 2022, scientists from 10 countries agreed that there is no link between electromagnetic radiation from cell phones and cancer.

According to the latest meta-study, there is no link between smartphone use and cancer.

A new meta-study (a study analyzing other published studies) by the World Health Organization (WHO) found no evidence that cell phone use causes brain cancer. This extensive review includes research from 22 countries and 63 studies published between 1994 and 2022. Based on them, no connection was found between the use of mobile phones and the development of gliomas, meningiomas, acoustic neuromas, or tumors of the pituitary gland, salivary glands or leukemia in adults and children . The authors of the meta-study were experts from 11 organizations from ten countries.

Cell phones transmit low-power electromagnetic radiation (RF-EMF), which, according to this meta-analysis, does not have the ability to damage DNA or cause ionization of electroneutral atoms and molecules. These waves are considered harmless. When the phone is on, it is a receiver of RF-EMF signals, but when it is off, it does not transmit or receive these signals.

The meta-study also found no evidence that exposure to radiation from fixed transmitters, such as broadcast antennas (BTS), is associated with childhood leukemia or brain tumors in children. The results of the study confirmed that RF-EMF transmitters in the workplace are not associated with an increased incidence of gliomas.

The IARC previously classified cell phones as “possibly carcinogenic,” but this new review suggests that concerns about cell phone cancer are unfounded.

However, the researchers stress the importance of further research as technology is rapidly evolving and using radio waves in different ways. Older studies that suggested a potential risk were criticized for methodological flaws. This new review provides a higher quality of evidence and refutes previous concerns about an increased risk of cancer.